Latest News
TEGNA Inc (NYSE:TGNA) Q4 2025 Earnings: Profit Beat Offsets Revenue Miss Amid Pending Acquisitionchartmill.com
Via Chartmill · March 2, 2026

Freeport-McMoRan has outperformed the Dow Jones Industrial Average over the past year. Moreover, Wall Street analysts remain strongly optimistic about its prospects.
Via Barchart.com · March 2, 2026
Dyne Therapeutics Inc (NASDAQ:DYN) Reports Narrower-Than-Expected Q4 2025 Loss, Reaffirms Key Clinical Timelineschartmill.com
Via Chartmill · March 2, 2026
XERIS BIOPHARMA HOLDINGS INC (NASDAQ:XERS) Surges on Strong Q4 Earnings and Robust 2026 Outlookchartmill.com
Via Chartmill · March 2, 2026
Astrana Health Inc (NASDAQ:ASTH) Reports Strong Q4 Earnings Beat and 42.9% Revenue Growthchartmill.com
Via Chartmill · March 2, 2026
Sealed Air Corp (NYSE:SEE) Beats Q4 Earnings and Revenue Estimateschartmill.com
Via Chartmill · March 2, 2026
uniQure (NASDAQ:QURE) Stock Plummets 40% Despite Earnings Beat on FDA Setback for AMT-130chartmill.com
Via Chartmill · March 2, 2026
WhiteHorse Finance Inc (NASDAQ:WHF) Reports Mixed Q4 2025 Results, Beats on EPS but Misses on Revenuechartmill.com
Via Chartmill · March 2, 2026
BALL CORP (NYSE:BALL) Shows Strong Technical Setup for Potential Breakoutchartmill.com
Via Chartmill · March 2, 2026
ADT Inc. (NYSE:ADT) Reports Mixed Q4 2025 Results, Meets EPS Estimates but Misses on Revenuechartmill.com
Via Chartmill · March 2, 2026
Via MarketBeat · March 2, 2026
Apogee Therapeutics (NASDAQ:APGE) Reports Q4 2025 Results, Highlights Cash Runway and Key 2026 Clinical Catalystschartmill.com
Via Chartmill · March 2, 2026
Via Talk Markets · March 2, 2026

Arcellx shares have jumped 75% in 2026, but that's because the stock will soon be off the market.
Via The Motley Fool · March 2, 2026

Arcellx shares have jumped 75% in 2026, but that's because the stock will soon be off the market.
Via The Motley Fool · March 2, 2026
The AI build-out is making a handful of companies a lot of money.
Via The Motley Fool · March 2, 2026
Dentsply Sirona (XRAY) reported mixed Q4 results, missing earnings but beating sales estimates. FY2026 projections below market expectations.
Via Benzinga · March 2, 2026
Every investor wants to identify a stock that can produce life-changing returns.
Via The Motley Fool · March 2, 2026
Innovative Solutions & Support (NASDAQ:ISSC) Emerges as a Top CAN SLIM Growth Prospectchartmill.com
Via Chartmill · March 2, 2026
Via Talk Markets · March 2, 2026

Toll Brothers (TOL) value score hits 90.50. With a Q1 earnings beat and bullish $175 price target, is this luxury builder undervalued?
Via Benzinga · March 2, 2026
Piper Sandler has revised its rating for cybersecurity firm CrowdStrike Holdings (NASDAQ: CRWD), identifying artificial intelligence (AI) as a significant growth catalyst rather than a threat.
Via Benzinga · March 2, 2026

U.S. stock futures lower, Dow futures down 1%. Yatsen Holding shares fall 10.1%, while other stocks also down in pre-market trading.
Via Benzinga · March 2, 2026
These dominant consumer-facing companies each have their own investment merits.
Via The Motley Fool · March 2, 2026

Wall Street analysts changed ratings on top stocks. Check out analyst ratings page for full list. NVO downgraded from Buy to Neutral with $41 target.
Via Benzinga · March 2, 2026

The company has opened a new integrated headquarters in Florida for drone testing and non-lethal response training.
Via Stocktwits · March 2, 2026
Ascendis Pharma shares rise after FDA approves Yuviwel, a weekly treatment for children with achondroplasia.
Via Benzinga · March 2, 2026
Via Benzinga · March 2, 2026
Via Benzinga · March 2, 2026
Via Talk Markets · March 2, 2026
Read inspirational quotes about living life to the fullest, putting meaning into life and staying true to your principles.
Via Investor's Business Daily · March 2, 2026

Via Benzinga · March 2, 2026
Prediction markets are now bearish on Bitcoin, and that could limit its future upside potential.
Via The Motley Fool · March 2, 2026

Wall Street analysts changed outlook on top names: BTIG cut CRWD PT, Piper Sandler cut BSY PT, RBC Capital cut AARD PT, TD Cowen raised TWLO PT, Morgan Stanley raised FLYW PT, Stifel boosted QSR PT, Morgan Stanley increased ZION PT, HC Wainwright cut IMUX PT
Via Benzinga · March 2, 2026
Via Talk Markets · March 2, 2026
EOG Resources has underperformed the Dow over the past year, yet Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.
Via Barchart.com · March 2, 2026
Stephen Weiss picks QXO, Inc. as his final trade following disappointing earnings. Jim Lebenthal recommends Exxon Mobil.
Via Benzinga · March 2, 2026